MICB and neoplasm: All of these molecules, as previously explained, in their soluble form, act by inducing immunosuppression in the tumor immune microenvironment: MICB prevents NK cells from performing their functions, GAL3 induces T-cell apoptosis and TCR downregulation, and CD276 inhibits the function and survival of T-cells.